Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
21.12
-0.74 (-3.39%)
Oct 17, 2025, 4:00 PM EDT - Market closed
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.53 billion as of October 17, 2025. Its market cap has increased by 54.34% in one year.
Market Cap
1.53B
Enterprise Value
1.29B
1-Year Change
54.34%
Ranking
Category
Stock Price
$21.12
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.53B, an increase of 139.81%. That is a compound annual growth rate of 20.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.53B | 46.89% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | 636.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |